“What Makes Us Different as Agents”
I was asked once why I decided to offer semen in the US. My response is EASY. I wanted to help Americans find the best stallions for THEIR mares even if we don’t offer that particular Stallion. As a judge and breeder, my goal is for the improvement of American horses. I offer advice (whatever it is worth) as a sportshorse judge and look at the mares via video and photos and hope to find a good match for that mare. I speak to the owners about their goals for the foal.
We donate annually to the NAWPN Stallion auction or the Annual Meeting. This donation of semen comes directly out of our pocket since we don’t stand stallions and can’t go out and collect a dose.
We send each batch of our purchased semen to the Gluck Research Center in KY for testing. (This is a question that any agent should be asked before purchasing)
We’ve been selling semen since 1998 and have developed long lasting relationships with breeders and owners of stallions in Europe. This relationship provides us with an insight about the stallions that other agents might not have. It gives us the “nitty gritty” about each stallion – data not normally out there.
These are all things that make us unique. Our goal is to not just provide semen and make a $ but to assist Americans to become the Best!!!
Frozen vs. Cooled Semen
by: Pete Sheerin, DVM, Dipl. ACT
Reprinted from TheHorse.com
Generally, any time you manipulate semen, the per-cycle pregnancy rate decreases. The rate should be highest for fresh semen, then shipped semen, followed by frozen-thawed semen. This assumes a reproductively healthy mare and stallion. Per-cycle pregnancy rates with frozen-thawed semen are reported to range from 0 to 70%.
Therefore, it is important to do a little homework prior to choosing to use frozen semen. It is important to know the first-cycle pregnancy rate for that stallion’s frozen-thawed semen. This information is also important when using shipped-cooled semen. Next one needs to know how the mares were bred to achieve this pregnancy rate. Were the mares bred before, after, or before and after ovulation? Also, were the mares bred with a full dose (and what constitutes a full dose for that particular stallion) or was a dose split in half to allow breeding before and after ovulation? Was the semen deposited in the uterine body or was deep horn insemination used?
In order to achieve the stallion’s reported pregnancy rate, you must be able to repeat the breeding management used to obtain those rates.
Mare selection also plays a role in the success or failure of frozen thawed semen. A reproductively healthy mare should always be used when fertilizing with frozen-thawed semen. Older maiden mares should be avoided because the cervix is not able to relax properly in many of these mares. There is an inflammatory response to insemination with frozen-thawed semen.
One aspect of an inflammatory response is fluid production by the uterus. If the cervix does not relax properly to allow the fluid to escape, the inflammation increases (as does fluid production and accumulation), and a vicious cycle begins. There is more effort and cost associated with the use of frozen-thawed semen, but this can be decreased if multiple doses of semen are available. In conclusion, success with frozen-thawed semen is stallion- and mare-dependent. If you have a reproductively sound mare and can find a stallion that has good fertility with his frozen-thawed semen, you can be successful.
AAEP Convention 2005: Optimizing Pregnancy Rates for Frozen-Thawed Semen
By Chad Mendell, Managing Editor
February 17, 2006 Article # 6555
A major disadvantage associated with frozen-thawed semen is the fertility of the semen, which can be considerably less than fresh semen. This can be problematic when deciding how many progressively motile sperm (PMS) are needed per breeding to produce optimal pregnancy rates in mares. Elizabeth Metcalf, MS, DVM, Dipl. ACT, of Honahlee PC equine clinic in Oregon, presented her findings regarding varied concentrations of motile sperm in frozen semen doses at the 51st Annual American Association of Equine Practitioners Convention, held in Seattle, Wash., Dec. 3-7, 2005.
“Motility does not always reflect fertility,” Metcalf said. “When we examine the motility of sperm, we have to realize that many other factors affect the pregnancy rates of fertile mares.”
Her study included 90 mares bred over 312 cycles with frozen-thawed semen from 46 stallions, which represented a large number of breeds (Quarter Horse, Thoroughbred, Paint, Morgan, Arab, etc.). Mares were bred 36 to 44 hours after administration of deslorelin (hCG, a heat-cycle inducing agent). The mares ideally would ovulate between breedings.
“The total amount of sperm inseminated into each mare, per cycle, ranged from less than 100 to more than 800 million progressively motile sperm,” Metcalf explained. Pregnancy rates in the study increased in correlation to the number of PMS used, peaking at 600-800 PMS (88.2%), and then decreasing at higher concentrations.
“More is not better here,” Metcalf explained. “More than 800 million progressively motile sperm yielded significantly lower pregnancy rates than lower doses.” She explained that this could be due to a less fertile population of mares or an unresolved inflammatory response secondary to presence of large numbers of sperm.
“Insemination pre-ovulation and post-ovulation yielded higher pregnancy rates than a single post-ovulation dose,” Metcalf said.
“The study suggests the number of sperm we should be using per dose–between 600-800 million progressively motile sperm split into two doses,” Metcalf said. “It also suggests a protocol for breeding mares at 36 and 44 hours” after giving an ovulation-inducing medication.
In: 49th Annual Convention of the American Association of Equine Practitioners, 2003 – New Orleans, LA, USA, (Ed.)
Publisher: American Association of Equine Practitioners, Lexington KY
Internet Publisher: International Veterinary Information Service, Ithaca NY (www.ivis.org), 2003; P0654.1103
Simplified Strategy for Insemination of Mares with Frozen Semen (Last Updated: 21-Nov-2003)
E. L. Squires1, S. Barbacini2, D. Necchi3, H. P. Reger4 and J. E. Bruemmer5
1,4,5Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, CO, USA.
2,3Studio Veterinario Cristella, San Daniele PO, Cremona, Italy.
The reproductive management of mares inseminated with frozen-thawed semen can be similar to that for mares inseminated with cooled semen. Examination of the mare with ultrasonography once a day and insemination of frozen-thawed semen 24 and 40 h after human chorionic gonadotropin (hCG) injection provided similar fertility to those examined three or four times a day and inseminated within 6 h post-ovulation. Furthermore, by inseminating the mare with 400 x 10 6 sperm twice in a cycle, the number of frozen-thawed sperm used to obtain pregnancy was identical to that of mares inseminated once post-ovulation. Deep uterine insemination into the uterine horn by a rectally guided approach did not improve pregnancy rates over those of mares inseminated into the uterine body.
Expanded use of frozen semen in the equine industry is dependent on simplified breeding strategies. Mares bred with frozen semen are often examined four to six times per day and inseminated immediately before or within 6 h post-ovulation. This is based on the premise that frozen-thawed spermatozoa do not survive as long in the mare’s reproductive tract as fresh or cooled semen. Furthermore, this strategy is partly because stallion owners provide only limited doses of frozen semen for each mare. If multiple doses of frozen semen were available each cycle, mares could be examined only once per day with ultrasonography and inseminated once or twice in a cycle. There are two criticisms of this strategy: (1) more semen per cycle would be used and (2) the mare would develop greater post-breeding endometritis if inseminated twice in a cycle with frozen-thawed spermatozoa. Decreasing the dose per insemination or depositing the semen at the tip of the uterine horn may allow one to decrease the number of sperm used to breed mares with frozen semen. Workers in France [1,2] demonstrated that fertility was improved when mares were inseminated more than once in a cycle with frozen semen. Recently, Metcalf  reported that insemination of mares twice in a cycle with frozen semen did not impair fertility and did not increase the incidence of post-breeding endometritis.
This report contains results of a controlled study (Colorado State University) and results of a clinical field trial (Italy).
2. Materials and Methods
The objective of the first experiment was to determine embryo recovery rates of mares inseminated with either 800 x 106 total frozen-thawed sperm 6 h post-ovulation or 400 x 106 total frozen-thawed sperm at 24 and 40 h after administration of human chorionic gonadotropin (hCG). Forty light-horse mares between 3 and 15 yr of age were synchronized with altrenogest [a] for 10 days, followed by prostaglandin on day 10. On returning to estrus, once a mare had acquired a follicle > 35 mm and uterine edema was observed, hCG [b] (2500 IU) was administered intravenously at 8:00 p.m. Mares were randomly assigned to one of two groups. Group 1 was scanned at 6:00 a.m., 12:00 p.m., and 6:00 p.m. until ovulation was detected, at which time they were inseminated with 800 x 106 frozen-thawed spermatozoa. Two mares ovulated between 6:00 p.m. and 6:00 a.m. and were excluded from the data. Mares in group 2 were scanned once daily with ultrasonography and inseminated 24 and 48 h after administration of hCG with 400 x 106 frozen-thawed spermatozoa. Frozen semen for this trial was obtained from three stallions. Each stallion was represented equally in both groups, and his semen was used to inseminate 12 – 14 mares. Ejaculates were frozen in a lactose-ethylenediamine tetra-acetic (EDTA) extender at a concentration of 400 x 106 sperm/ml in 0.5 ml. Within 5 min of thawing semen, mares were inseminated with the appropriate dose into the body of the uterus. Between 7 and 9 days after ovulation, embryo flushes were performed on all mares, and embryo recovery was recorded.
The objective of the second experiment was to determine if insemination into the uterine horn produced higher pregnancy rates than insemination into the uterine body. Forty mares were randomly assigned to one of two groups: body versus horn insemination. As mares developed a follicle > 35 mm and uterine edema, hCG was administered at 8:00 p.m. Mares that had received hCG more than twice in a breeding season were administered deslorelin acetate [c] at 10:00 p.m. At 24 and 40 h after administration of hCG, or 30 and 46 h after deslorelin acetate administration, mares were inseminated with 200 x 106 frozen-thawed spermatozoa into either the uterine body (group 1) or uterine horn (group 2). A dose of 200 x 106 frozen-thawed spermatozoa was selected to allow insemination of only one straw and to determine if insemination of a low number of frozen-thawed sperm into the tip of the uterine horn could improve pregnancy rates over insemination into the uterine body. The 0.5-ml frozen-thawed straw was loaded into a universal pipette catheter [d] that was seated in a universal pipette [e]. In group 1, semen was deposited just inside the cervix in the body of the uterus. In group 2, semen was deposited at the tip of the horn ipsilateral to the preovulatory follicle or ovulation. The inseminator palpated the horn and ovary transrectally and guided the pipette to the tip of the horn. At 7 – 9 days post-ovulation, mares were flushed for embryos, and embryo recovery rates were recorded.
Clinical Field Trial
Forty-eight Warmblood, cycling mares to be inseminated with commercial frozen semen were used. Mares were < 16 yr of age. Seven Warmblood stallions were selected for their freezability and frozen semen fertility. Only doses containing at least 250 x 106 progressively motile spermatozoa and having a minimum of 30% progressive motility were used to inseminate mares. Mare were inseminated according to one of two insemination protocols. Group 1 mares (n = 18) were examined with ultrasound 12 h after hCG injection and then every 4 h until ovulation was detected. A single insemination was then performed within 6 h post-ovulation. Group 2 mares (n = 30) were examined with ultrasound daily and inseminated at 24 and 40 h after hCG injection. The second insemination was always performed, even if ovulation was detected at 40 h post-hCG. Both groups of mares were scanned with ultrasound 24 h after the last insemination to identify post-insemination fluid accumulations. Pregnancies were detected at 14 days post-ovulation and again at days 30 and 50 of gestation.
In experiment 1, embryo recovery rates were not different when mares were inseminated using timed insemination (24 and 40 h after administration of hCG) versus insemination after ovulation (11 of 20, 55% versus 12 of 20, 60%, respectively). In experiment 2, embryo recovery rates were lower for mares inseminated in the ipsilateral horn versus into the uterine body (4 of 20, 20% versus 10 of 20, 50%, respectively).
Clinical Field Trial
Pregnancy rates were not different for mares inseminated once within 6 h post-ovulation (83.3%) versus those inseminated 24 and 40 h after hCG administration (86.6%). These pregnancy rates are quite high for frozen semen and probably reflect the selection of very fertile stallions. Accumulation of uterine fluid post-insemination was not different (P > 0.05) between the two groups of mares. Uterine fluid was observed in 11.7% of the cycles in mares inseminated once versus 9.5% of the time for mares inseminated twice during the cycle. Furthermore, there was no incidence of embryonic loss between 15 and 30 days for either group of mares in this study.
One of the major deterrents to the use of frozen semen is the increased mare management required for proper timing of insemination in relation to ovulation. However, the results of both the controlled study and the clinical study demonstrated that daily examinations with ultrasonography were sufficient when mares were inseminated at a fixed time after hCG administration. Although post-ovulatory insemination resulted in similar fertility, these mares had to be examined three to four times per day to time the insemination within 6 h post-ovulation. Woods et al.,  have demonstrated that delaying insemination beyond 8 h after ovulation resulted in a depression of fertility with fresh semen. Vidament et al.,  in a large field trial in France, demonstrated that more than one insemination per cycle with frozen-thawed spermatozoa increased pregnancy rates. The basis as to why timed insemination 24 and 40 h after hCG administration provides acceptable fertility is based on having sperm available in the female reproductive tract covering a period of time from 18 to 52 h after hCG administration. Assuming that a mare ovulates any time during this interval, sperm in one of the two inseminates should be viable and be available for fertilization.
One argument against insemination of mares more than once in each cycle is the increased use of semen. However, the controlled study demonstrated that halving the dose and inseminating mares twice during the cycle resulted in similar fertility compared with mares inseminated with a full dose of semen within 6 h after ovulation. It has been suggested that insemination twice during the cycle with frozen-thawed semen may result in a higher incidence of post-breeding endometritis. However, the incidence of mares having uterine fluid 24 h after insemination in the controlled study was similar between the two groups. Furthermore, in the clinical trial, the incidence of post-breeding endometritis was also similar between the two groups; less than 10% of the cycles resulted in fluid accumulation 24 h after insemination. Metcalf et al.,  had previously demonstrated that insemination with frozen-thawed semen twice during the cycle did not increase the incidence of post-breeding endometritis. Possibly, one of the reasons for the low incidence of post-breeding endometritis in this study was selection of mares for the study. In the controlled study, mares were between 3 and 15 yr of age, and in the clinical study, all mares were less than 16 yr of age. It is likely that if older mares are inseminated twice in a cycle with frozen-thawed spermatozoa, the incidence of post-breeding endometritis may be greater.
Once semen is deposited into the body of the uterus, the spermatozoa move relatively quickly to the uterotubal junction or the distal isthmus of the oviduct. Of the millions of sperm placed in the uterus, only a few thousand spermatozoa can be found in the oviduct . There are several studies that demonstrate that pregnancies can be obtained with low numbers of spermatozoa if the sperm are placed onto the uterotubal junction [6-8]. The second controlled study was designed to determine if deep uterine insemination would improve pregnancy rates when a fourth of the normal dose of frozen-thawed spermatozoa was inseminated. Unexpectedly, in this study, pregnancy rates were higher if mares were inseminated into the uterine body versus the uterine horn. It may be that the inexperienced technician did not properly position the catheter onto the uterotubal junction or perhaps the added insult of inseminating the mare twice (24 and 40 h after hCG) may have caused a more severe uterine reaction that decreased fertility.
Recently in our laboratory, Lindsey et al.,  reported a higher pregnancy rate with videoendoscopic insemination of 5 x 106 spermatozoa versus insemination of the same sperm number using deep uterine insemination. Rigby et al.,  reported similar pregnancy rates for videoendoscopic insemination versus deep uterine, rectally guided insemination. Further studies with larger numbers of mares are needed to truly evaluate the advantage of insemination to the uterotubal junction using a rectally guided approach. The difference may also have been because of chance caused by the low number of mares in these studies. However, recently, a lower pregnancy rate was reported [f] if problem mares were inseminated on the uterotubal junction (UTJ) compared with those inseminated in the uterine body.
[a] Regumate, Intervet Inc., Millsboro, DE 19966-0318.
[b] Chorulon, Intervet Inc., Millsboro, DE 19966-0318.
[c] Ovuplant, Fort Dodge Animal Health, Ft Dodge, IA 66210.
[d] Minitube pipette catheter, Minitube of America, Inc., Verona, WI 53593- 0187.
[e] Minitube pipette, Minitube of America, Inc., Verona, WI 53593-0187.
[f] Sieme et al., Celle, ND Germany, (Personal Communication) 2003.
All rights reserved. This document is available on-line at www.ivis.org. Document No. P0654.1103.